Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Villano, John L."" wg kryterium: Autor


Tytuł:
Case report: A unique presentation of a high-grade neuroepithelial tumor with EWSR1::PATZ1 fusion with diagnostic, molecular, and therapeutic insights.
Autorzy:
Ene, Andre
Jing Di
Neltner, Janna H.
Pittman, Thomas
Arnold, Susanne M.
Kolesar, Jill M.
Villano, John L.
Bachert, Sara E.
Allison, Derek B.
Pokaż więcej
Temat:
NEUROECTODERMAL tumors
YOUNG adults
CENTRAL nervous system
Źródło:
Frontiers in Oncology; 1/31/2023, Vol. 13, p1-6, 6p
Czasopismo naukowe
Tytuł:
Real-World Evaluation of Universal Germline Screening for Cancer Treatment-Relevant Pharmacogenes.
Autorzy:
Hutchcraft, Megan L. (AUTHOR)
Lin, Nan (AUTHOR)
Zhang, Shulin (AUTHOR)
Sears, Catherine (AUTHOR)
Zacholski, Kyle (AUTHOR)
Belcher, Elizabeth A. (AUTHOR)
Durbin, Eric B. (AUTHOR)
Villano, John L. (AUTHOR)
Cavnar, Michael J. (AUTHOR)
Arnold, Susanne M. (AUTHOR)
Ueland, Frederick R. (AUTHOR)
Kolesar, Jill M. (AUTHOR)
Pokaż więcej
Źródło:
Cancers. Sep2021, Vol. 13 Issue 18, p4524. 1p.
Czasopismo naukowe
Tytuł:
Phase II Trial of Carfilzomib Plus Irinotecan in Patients With Small-cell Lung Cancer Who Have Progressed on Prior Platinum-based Chemotherapy.
Autorzy:
Arnold, Susanne M.
Chansky, Kari
Baggstrom, Maria Q.
Thompson, Michael A.
Sanborn, Rachel E.
Villano, John L.
Waqar, Saiama N.
Hamm, John
Leggas, Markos
Willis, Maurice
Rosales, Joseph
Crowley, John J.
Pokaż więcej
Źródło:
Clinical Lung Cancer; Jul2020, Vol. 21 Issue 4, p357-357, 1p
Czasopismo naukowe
Tytuł:
NRG/RTOG 1122: A phase 2, double-blinded, placebo-controlled study of bevacizumab with and without trebananib in patients with recurrent glioblastoma or gliosarcoma.
Autorzy:
Lee, Eudocia Q. (AUTHOR)
Zhang, Peixin (AUTHOR)
Wen, Patrick Y. (AUTHOR)
Gerstner, Elizabeth R. (AUTHOR)
Reardon, David A. (AUTHOR)
Aldape, Kenneth D. (AUTHOR)
deGroot, John F. (AUTHOR)
Pan, Edward (AUTHOR)
Raizer, Jeffrey J. (AUTHOR)
Kim, Lyndon J. (AUTHOR)
Chmura, Steven J. (AUTHOR)
Robins, H. Ian (AUTHOR)
Connelly, Jennifer M. (AUTHOR)
Battiste, James D. (AUTHOR)
Villano, John L. (AUTHOR)
Wagle, Naveed (AUTHOR)
Merrell, Ryan T. (AUTHOR)
Wendland, Merideth M. (AUTHOR)
Mehta, Minesh P. (AUTHOR)
Pokaż więcej
Źródło:
Cancer (0008543X). Jun2020, Vol. 126 Issue 12, p2821-2828. 8p.
Czasopismo naukowe
Tytuł:
A probabilistic method for leveraging functional annotations to enhance estimation of the temporal order of pathway mutations during carcinogenesis.
Autorzy:
Wang M; Department of Statistics, University of Kentucky, Lexington, USA.
Yu T; Department of Molecular & Cellular Biology, Roswell Park Comprehensive Cancer Center, Buffalo, USA.
Liu J; Markey Cancer Center, University of Kentucky, Lexington, USA.
Chen L; Markey Cancer Center, University of Kentucky, Lexington, USA.; Department of Biostatistics, University of Kentucky, Lexington, USA.
Stromberg AJ; Department of Statistics, University of Kentucky, Lexington, USA.
Villano JL; Markey Cancer Center, University of Kentucky, Lexington, USA.; Department of Internal Medicine, University of Kentucky, Lexington, USA.
Arnold SM; Markey Cancer Center, University of Kentucky, Lexington, USA.; Department of Internal Medicine, University of Kentucky, Lexington, USA.
Liu C; Markey Cancer Center, University of Kentucky, Lexington, USA.; Department of Molecular & Cellular Biochemistry, University of Kentucky, Lexington, USA.
Wang C; Markey Cancer Center, University of Kentucky, Lexington, USA. .; Department of Biostatistics, University of Kentucky, Lexington, USA. .
Pokaż więcej
Źródło:
BMC bioinformatics [BMC Bioinformatics] 2019 Dec 02; Vol. 20 (1), pp. 620. Date of Electronic Publication: 2019 Dec 02.
Typ publikacji:
Journal Article
MeSH Terms:
Molecular Sequence Annotation*
Probability*
Carcinogenesis/*genetics
Mutation/*genetics
Signal Transduction/*genetics
Computer Simulation ; Databases, Genetic ; Humans ; Mutation Rate ; Neoplasms/genetics ; Reproducibility of Results ; Time Factors
Czasopismo naukowe
Tytuł:
Comprehensive evaluation of treatment and outcomes of low-grade diffuse gliomas.
Autorzy:
Garcia CR; Markey Cancer Center, University of Kentucky, Lexington, Kentucky, United States of America.
Slone SA; Division on Cancer Biostatistics, University of Kentucky, Lexington, Kentucky, United States of America.
Pittman T; Department of Neurosurgery, University of Kentucky, Lexington, Kentucky, United States of America.
St Clair WH; Department of Radiation Oncology, University of Kentucky, Lexington, Kentucky, United States of America.
Lightner DD; Department of Neurology, University of Kentucky, Lexington, Kentucky, United States of America.
Villano JL; Markey Cancer Center, University of Kentucky, Lexington, Kentucky, United States of America.; Department of Neurosurgery, University of Kentucky, Lexington, Kentucky, United States of America.; Department of Neurology, University of Kentucky, Lexington, Kentucky, United States of America.; Department of Medicine, University of Kentucky, Lexington, Kentucky, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2018 Sep 20; Vol. 13 (9), pp. e0203639. Date of Electronic Publication: 2018 Sep 20 (Print Publication: 2018).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Glioma/*drug therapy
Glioma/*surgery
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Brain Neoplasms/drug therapy ; Brain Neoplasms/metabolism ; Brain Neoplasms/radiotherapy ; Brain Neoplasms/surgery ; Chromosomes, Human, Pair 1/genetics ; Chromosomes, Human, Pair 19/genetics ; Female ; Glioma/metabolism ; Glioma/radiotherapy ; Humans ; Isocitrate Dehydrogenase/metabolism ; Male ; Middle Aged ; Young Adult
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies